Insight

Could blood, sweat and tear biomarkers transform women’s health diagnostics?

By Published On: November 21, 2024
Could blood, sweat and tear biomarkers transform women’s health diagnostics?

In 2021, 1 in 5 women died from heart disease in the United States. Could a simple blood test warn women of their cardiovascular disease risk decades in advance?

Although mammograms are the gold standard for breast cancer detection, millions of women globally don’t have access to them. What if breast cancer could be detected using tears? 

Monitoring fertility-related hormones can be uncertain and time-consuming. Could a sweat measuring wearable revolutionise fertility tracking? 

Yes, thanks to recent advances in women’s health biomarker measurement and monitoring. 

What Are Biomarkers? 

Biomarkers are biological indicators that can be measured to assess a range of health conditions.

These indicators can include genetic markers, hormonal levels, and metabolic profiles, which help in understanding conditions that disproportionately affect women, such as breast cancer, autoimmune diseases, and reproductive health issues.

Biomarker data can be used to power personalised medicine, or the development of tailored treatment plans based on individual health profiles.

A rising trend in women’s health is an increased focus on using diagnostic tools to identify disease markers — especially in areas such as breast and cervical cancer — as early as possible.

As a result, advanced diagnostic tools and tests are being developed to provide more accurate and timely assessments of women’s health conditions. 

Blood, Sweat and Tear-Powered Next-Generation Women’s Health Diagnostics

Over the past decade, there have been significant advances in the ability to detect women’s health biomarkers in blood, sweat and tears.

Currently, a range of innovators are (or are in the process) of commercialising blood, sweat and tear-based diagnostics in cancer, heart disease and a range of other areas.

Measuring Blood Biomarkers

Even though many blood biomarkers are well-understood, new discoveries are uncovering disease signals highly relevant to women’s health.

In cardiovascular disease, a study from Brigham and Women’s Hospital highlighted three blood biomarkers—low-density lipoprotein cholesterol (LDL-C), high-sensitivity C-reactive protein (hsCRP), and lipoprotein(a) (Lp(a))—that can better predict the risk heart attack, stroke and other cardiovascular events in women up to 30 years in advance. 

Sweat Content as a Health Indicator

Sweat contains a wide range of biomarkers, including metabolites, electrolytes, trace elements, and small amounts of macromolecules, that can provide valuable insights into overall health and disease states.

Research has revealed that there is a strong relationship between the levels of biomarkers in sweat and blood, making sweat a non-invasive means for health assessments and disease diagnoses.

Sweat can be used to measure physical — and mental health status.

For example, people with depression have increased levels of certain proteins, which can be detected through sweat.

Tracking the hormone oestradiol, which can also be measured in sweat, can provide important information about female fertility. 

Tear-Powered Diagnostics

Tears have many biomarkers such as proteins, lipids, electrolytes, and metabolites that can be used to detect various conditions such as eye tumours and even cancer.

In 2020, researchers at Kobe University developed a technology to detect breast cancer using the exomes found in tears.

Exomes are involved in the spread of cancer and have become an important cancer biomarker.

Signaling the importance of tears in health monitoring, the Advanced Research Projects Agency for Health, is currently funding the development of a “tear-based biomarker measurement system that can be inserted into the tear duct for continuous health monitoring.” 

Pioneers in Women’s Health Blood, Sweat and Tear-Based Biomarker Monitoring  

Source: Femalytics

Research and product development in new women’s health biomarkers is accelerating rapidly.

Here are six pioneers developing solutions in blood, sweat and tears biomarkers. 

  • Endometrics:  The company has created a solution for the non-invasive diagnosis of endometriosis using a menstrual blood sample and proprietary genomic biomarker. W: https://endometrics.us
  • Qvin: Developers of an FDA-cleared menstrual pad that collects blood for lab testing. The pad currently monitors blood sugar levels and is being expanded to track C-reactive protein, thyroid-stimulating hormone and other key biomarkers relevant to women’s health. W: https://qvin.com
  • Persperity Health: Developing a continuous biosensor technology that delivers real-time insights into fertility and hormone health via sweat. W: https://persperityhealth.com
  • DIA: Creating a sensor that enables real-time measurements of endogenous and exogenous chemicals in sweat (hormones, electrolytes and inflammatory markers). W: https://www.diasensor.com 
  • Namida Lab: Developers of Auria, a breast health assessment test for women, ages 33-85 with an average risk of developing breast cancer. Auria identifies protein biomarkers related to breast abnormalities via tears. W: https://namidalab.com 
  • TearExo: Development-stage company developing a product that uses chemical nano-processing technology to detect breast cancer using exosomes found in tears. W: http://tearexo.jp

Where Did These Insights Come From?

Innovation data in this article was sourced from Femalytics, an intelligence and membership platform for women’s health change-makers featuring thousands of market insights and data on more than 34,000 companies.

Femalytics features Femmaya, a unique AI innovation assistant, helping members surface insights from the Femalytics database.

Join Femalytics for free to start accessing cutting-edge women’s health innovation intel and much more today.

About the Author

Fard Johnmar is a health futurist, strategist, and co-founder of the FemAging Project, a global initiative focused on providing insights, intelligence and connections to help drive women’s health innovation — especially for those aged 40+.

Femalytics is a FemAging Project initiative. 

The intersection of femtech and mental health
OB-GYN innovators to be recognised at Femtech World Awards